Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Disease on EC 1.14.11.54 - mRNA N1-methyladenine demethylase

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Burkitt Lymphoma
Tp44 molecules involved in antigen-independent T cell activation are expressed on human plasma cells.
Carcinoma
High expression of a new marker PCA-1 in human prostate carcinoma.
Prostate cancer antigen-1 as a potential novel marker for prostate cancer.
Prostate cancer antigen-1 contributes to cell survival and invasion though discoidin receptor 1 in human prostate cancer.
[Expression of prostate cancer antigen-1 in prostate cancer and its clinical significance]
Carcinoma, Hepatocellular
Association of AlkB homolog 3 expression with tumor recurrence and unfavorable prognosis in hepatocellular carcinoma.
Cerebellar Ataxia
Cerebrospinal fluid ?? T cell frequency is age-related: a case-control study of 435 children with inflammatory and non-inflammatory neurological disorders.
Digestive System Neoplasms
Emerging Roles of N6-Methyladenosine Demethylases and Its Interaction with Environmental Toxicants in Digestive System Cancers.
Down Syndrome
Purkinje cell cytoplasmic antibody type 1 (anti-yo) autoimmunity in a child with down syndrome.
Encephalitis
Cerebrospinal fluid ?? T cell frequency is age-related: a case-control study of 435 children with inflammatory and non-inflammatory neurological disorders.
Encephalomyelitis
Cerebrospinal fluid ?? T cell frequency is age-related: a case-control study of 435 children with inflammatory and non-inflammatory neurological disorders.
Encephalomyelitis, Acute Disseminated
Cerebrospinal fluid ?? T cell frequency is age-related: a case-control study of 435 children with inflammatory and non-inflammatory neurological disorders.
Leukemia
Antigens on human plasma cells identified by monoclonal antibodies.
Leukemia, Plasma Cell
Antigens on human plasma cells identified by monoclonal antibodies.
Lung Neoplasms
TP53 gene status is a critical determinant of phenotypes induced by ALKBH3 knockdown in non-small cell lung cancers.
Monoclonal Gammopathy of Undetermined Significance
Restricted expression of immunoglobulin light chain mRNA and of the adhesion molecule CD11b on circulating monoclonal B lineage cells in peripheral blood of myeloma patients.
Selective expression of CD45 isoforms defines CALLA+ monoclonal B-lineage cells in peripheral blood from myeloma patients as late stage B cells.
Multiple Myeloma
Elimination of myeloma cells from bone marrow by using monoclonal antibodies and magnetic immunobeads.
Restricted expression of immunoglobulin light chain mRNA and of the adhesion molecule CD11b on circulating monoclonal B lineage cells in peripheral blood of myeloma patients.
Selective expression of CD45 isoforms defines CALLA+ monoclonal B-lineage cells in peripheral blood from myeloma patients as late stage B cells.
Neoplasms
Anti-yo associated paraneoplastic cerebellar degeneration in a man with large cell cancer of the lung.
Association of AlkB homolog 3 expression with tumor recurrence and unfavorable prognosis in hepatocellular carcinoma.
Design and synthesis of prostate cancer antigen-1 (PCA-1/ALKBH3) inhibitors as anti-prostate cancer drugs.
Elimination of myeloma cells from bone marrow by using monoclonal antibodies and magnetic immunobeads.
Emerging Roles of N6-Methyladenosine Demethylases and Its Interaction with Environmental Toxicants in Digestive System Cancers.
Hairy cell leukemia: a tumor of pre-plasma cells.
High expression of a new marker PCA-1 in human prostate carcinoma.
Immunologic heterogeneity of diffuse large cell lymphoma.
Paraneoplastic Cerebellar Degeneration (PCD) associated with PCA-1 antibodies in established cancer patients.
Paraneoplastic gastrointestinal motor dysfunction: clinical and laboratory characteristics.
Prostate cancer antigen-1 contributes to cell survival and invasion though discoidin receptor 1 in human prostate cancer.
Proteins of human urine. II. Identification by two-dimensional electrophoresis of a new candidate marker for prostatic cancer.
Response patterns of hairy cell leukemia to B-cell mitogens and growth factors.
[Expression of prostate cancer antigen-1 in prostate cancer and its clinical significance]
Neoplasms, Second Primary
Paraneoplastic Cerebellar Degeneration (PCD) associated with PCA-1 antibodies in established cancer patients.
Nervous System Diseases
Purkinje cell cytoplasmic antibody type 1 (anti-yo) autoimmunity in a child with down syndrome.
Ovarian Neoplasms
Paraneoplastic Cerebellar Degeneration (PCD) associated with PCA-1 antibodies in established cancer patients.
Paraneoplastic Cerebellar Degeneration
Paraneoplastic Cerebellar Degeneration (PCD) associated with PCA-1 antibodies in established cancer patients.
Paraneoplastic Syndromes
Paraneoplastic Cerebellar Degeneration (PCD) associated with PCA-1 antibodies in established cancer patients.
Paraproteinemias
Restricted expression of immunoglobulin light chain mRNA and of the adhesion molecule CD11b on circulating monoclonal B lineage cells in peripheral blood of myeloma patients.
Selective expression of CD45 isoforms defines CALLA+ monoclonal B-lineage cells in peripheral blood from myeloma patients as late stage B cells.
Plasmacytoma
Studies of in vitro activation and differentiation of human B lymphocytes. I. Phenotypic and functional characterization of the B cell population responding to anti-Ig antibody.
Pleural Effusion
Establishment of a monoclonal antibody to plasma cells: a comparison with CD38 and PCA-1.
Prostatic Hyperplasia
Anti-Tumor Effect of AlkB Homolog 3 Knockdown in Hormone- Independent Prostate Cancer Cells.
High expression of a new marker PCA-1 in human prostate carcinoma.
Proteins of human urine. II. Identification by two-dimensional electrophoresis of a new candidate marker for prostatic cancer.
Prostatic Intraepithelial Neoplasia
High expression of a new marker PCA-1 in human prostate carcinoma.
Prostate cancer antigen-1 as a potential novel marker for prostate cancer.
[Expression of prostate cancer antigen-1 in prostate cancer and its clinical significance]
Prostatic Neoplasms
Anti-Tumor Effect of AlkB Homolog 3 Knockdown in Hormone- Independent Prostate Cancer Cells.
Clinical significance and therapeutic potential of prostate cancer antigen-1/ALKBH3 in human renal cell carcinoma.
Design and synthesis of prostate cancer antigen-1 (PCA-1/ALKBH3) inhibitors as anti-prostate cancer drugs.
High expression of a new marker PCA-1 in human prostate carcinoma.
Improving the bioavailability and anticancer effect of the PCA-1/ALKBH3 inhibitor HUHS015 using sodium salt.
Novel Metabolically Stable PCA-1/ALKBH3 Inhibitor Has Potent Antiproliferative Effects on DU145 Cells
Prostate cancer antigen-1 as a potential novel marker for prostate cancer.
Prostate cancer antigen-1 contributes to cell survival and invasion though discoidin receptor 1 in human prostate cancer.
[Effect of downregulation of prostate cancer antigen-1 expression on malignant biological behavior of prostate cancer LNCaP cells].
[Expression of prostate cancer antigen-1 in prostate cancer and its clinical significance]